During the past decade, Hospital Sultanah Bahiyah conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 17 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 17 clinical trials were completed. i.e. 130.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Sultanah Bahiyah" #1 sponsor was "Allergan" with 4 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Celgene" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Sultanah Bahiyah" #1 collaborator was "Hospital Queen Elizabeth, Malaysia" with 3 trials as a collaborator, "Kuala Lumpur General Hospital" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Hospital Enche Besar Hajjah Khalsom, Kluang, Johor" with 2 trials as a collaborator and "Hospital Melaka, Melaka" with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Sultanah Bahiyah" are "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Anosmia" (2 trials), "COVID-19" (2 trials) and "Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "Hospital Sultanah Bahiyah" in a lesser frequency.

Most popular intervention types in "Hospital Sultanah Bahiyah" are "Drug" (27 trials), "Other" (5 trials), "Biological" (4 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Relamorelin" (3 trials), "JNJ-56136379" (2 trials), "Lansoprazole" (2 trials) and "Lansoprazole Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Sultanah Bahiyah" are 35 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Sultanah Bahiyah". 1 are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Hospital Sultanah Bahiyah, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Sultanah Bahiyah, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".